U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07454525) titled 'Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.' on Dec. 09, 2025.
Brief Summary: The purpose of this study is to build insights to understand how the placebo and active impacts the skin microbiome in women with high skin sensitivity (SS10 > 13) and sun exposure. Microbiome samples will be taken at baseline after 2 weeks of using the placebo (base without active) as a run-in period followed by the usage of placebo for an additional 4 weeks. The participants will then start the usage of active formula for an additional 8 weeks with microbiome samples collected at the 10-week an...